About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT07387237

Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

Multigene germeline panel test in gastric cancer patients

Lead sponsor: Unidade Local De Saúde Do Norte Alentejano•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Unidade Local De Saúde Do Norte Alentejano

We conducted a retrospective observational study including 51 patients with histologically confirmed gastric cancer who underwent MGPT between 2020 and 2025. Genetic testing was performed using validated 15 or 30 gene panels. Clinical, pathological, and survival data were retrieved from medical records.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Eligible participants were adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025;
•Ability to understand Portuguese and/or English;
•Ability to provide valid informed consent.
•Patients without a definitive genetic report or with incomplete clinical data for key study variables were excluded.

Related studies

RECRUITINGPhase 2

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

NCT07070466 · Stomach Cancer Stage IV, Esophagus Cancer, and more

Cancer Loyalty Card Study 2 (CLOCS-2)

NCT06447064 · Pancreatic Cancer, Colon Cancer, and more

RECRUITINGPhase 1

Brodalumab in the Treatment of Immune-Related Adverse Events

NCT06673329 · Breast Cancer, Esophageal Cancer, and more

Active Not RecruitingNA

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

NCT05931445 · Breast Cancer, Lung Cancer, and more

Active Not RecruitingPhase 2

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

NCT03488667 · Gastro Esophageal Junction Cancer, Stomach Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 4, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment51

Start dateSep 2023

Last updatedFeb 4, 2026

Condition

Gastric Cancer (Diagnosis)Stomach Cancer

Locations shown

Unidade Local de Saúde do Alto Alentejo

Portalegre

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 4, 2026Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions